Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Atrys Health, S.A. (A2T.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
6.14+0.16 (+2.68%)
At close: 01:33PM CET
Advertisement

Atrys Health, S.A.

Calle VelAzquez, 24
4th Floor Right
Madrid 28001
Spain
34 91 781 94 65
https://www.atryshealth.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees2,397

Key Executives

NameTitlePayExercisedYear Born
Mr. Santiago De Torres SanahujaExec. ChairmanN/AN/AN/A
Ms. Isabel Lozano FernandezCEO & Exec. DirectorN/AN/AN/A
Dr. Carlos Cordon-CardoFounder & Scientific VPN/AN/AN/A
Dr. Zvi FuchsFounder and Medical VPN/AN/AN/A
Mr. Jose Maria Huch GinestaChief Financial OfficerN/AN/AN/A
Carlos GirónChief Technology OfficerN/AN/AN/A
Encarna VegaAdmin. DirectorN/AN/AN/A
Ms. Maria MarinHead of Investor RelationsN/AN/AN/A
Ms. Gabriela CamunasGen. CounselN/AN/AN/A
Helena Vidal-FolchHead of CommunicationN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.

Corporate Governance

Atrys Health, S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement